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Abstract
Background: With HIV prevalence estimated at 20% among female injecting drug users (IDUs) in St. Petersburg,
Russia, there is a critical need to address the HIV risks of this at-risk population. This study characterized HIV risks
associated with injecting drug use and sex behaviors and assessed the initial feasibility and efficacy of an adapted
Woman-Focused intervention, the Women’s CoOp, relative to a Nutrition control to reduce HIV risk behaviors
among female IDUs in an inpatient detoxification drug treatment setting.
Method: Women (N = 100) were randomized into one of two one-hour long intervention conditions–the Woman-
Focused intervention (n = 51) or a time and attention-matched Nutrition control condition (n = 49).
Results: The results showed that 57% of the participants had been told that they were HIV-positive. At 3-month
follow-up, both groups showed reduced levels of injecting frequency. However, participants in the Woman-
Focused intervention reported, on average, a lower frequency of partner impairment at last sex act and a lower
average number of unprotected vaginal sex acts with their main sex partner than the Nutrition condition.
Conclusion: The findings suggest that improvements in sexual risk reduction are possible for these at-risk women
and that more comprehensive treatment is needed to address HIV and drug risks in this vulnerable population.
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Background
Russia is an emerging epicenter of the global HIV epi-
demic [1], accounting for 66% of all newly registered
HIV cases in Eastern Europe and Eurasia [2]. The geo-
graphical nexus of Russia’s HIV epidemic is St. Peters-
burg, with an HIV prevalence rate of 30-47% among
injecting drug users (IDUs) [3]. Additionally, 80-90% of
the HIV cases in St. Petersburg are associated with
IDUs, many of whom are unaware of their HIV status
[4-6]. Further, HIV morbidity is reported to be highest
among IDUs in St. Petersburg [7].
In earlier studies, Russian women in general and
female IDUs in particular appeared to be at high risk of
HIV, but HIV prevalence among them was relatively
low [8,9]. However, between 1996 and 2006, the number
of HIV-infected women increased rapidly from 29% to
44% [2,9]. In St. Petersburg, HIV prevalence among
female IDUs was estimated to be 20% [10]. Conse-
quently, there is a critical need to address the HIV risks
of female IDUs [11-13].
Because of the multifaceted risks women face, they are
at high risk for contracting and spreading HIV. For
example, sharing contaminated injecting equipment and
sexual transmission are the main causes of HIV infec-
tion for female IDUs [2,11,14]. Also, the power and con-
trol differential that female IDUs often experience in
heterosexual relationships heightens their risk of HIV
infection because out of fear of abuse by their sex part-
ner and/or the need to obtain daily necessities for
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practices [15].
Research suggests a high correlation between sex risk
behaviors and drug use [14,16]. Among IDUs, for exam-
ple, drug use may impair judgment and increase risky
sex behaviors, including unprotected sex, having multi-
ple sex partners, or exchanging sex for drugs and every-
day necessities [17]. In addition, injecting drug use has
been reported to be a major factor in the increase of
commercial sex workers in Russia [11]. Studies show
that 15-50% of female IDUs in Russia engage in com-
mercial sex work for money and/or drugs [8,11,18], yet
some women also trade sex only for drugs. Evidence
suggests that sexually active female IDUs, whether com-
mercial sex workers or not, are a most-at-risk popula-
tion in St. Petersburg and urgently need HIV prevention
interventions.
Consequently, this study aimed (1) to characterize the
risks for HIV associated with injecting drug use and sex
behaviors among female IDUs in drug treatment in St.
Petersburg, and (2) to assess the initial feasibility and
efficacy of an adapted Woman-Focused intervention, the
Women’s CoOp [19], in reducing HIV risk behaviors.
The Women’s CoOp is considered a best-evidence inter-
vention [20] and is based on empowerment theory [21]
and principles of social cognitive theory [22]. It focuses
on increasing education and information about sub-
stances to reduce use and gain personal power, enhan-
cing skills and self-efficacy of implementing condom
skills, and increasing assertiveness for protection within
relationships and sexual negotiations [23].
Methods
Adapting the Women’s CoOp Intervention and
Procedures
The formative research stage of this study used in-depth
interviews to examine the risk factors of Russian female
IDUs and to adapt the Women’s CoOp intervention.
Participants in the in-depth interviews included female
IDUs in the Leningrad Regional Center of Addictions
(LRCA), an inpatient substance abuse treatment center.
The interviews focused on learning more about drug
use and risk, understanding sexual risk, and informing
the adaptation of the Women’s CoOp intervention to
the Russian context [24].
The adaptation process involved modifying the origi-
nal Women’s CoOp to address injecting risks, adapting
an attention control Nutrition intervention to fit Russian
cultural food norms [25], making sure both interven-
tions had equal one-hour sessions (two total sessions for
each intervention), and translating both interventions
into Russian [26]. Also, the data collection instrument
used across the Women’s CoOp studies needed mea-
sures to be inserted for injecting risk and to be
translated and pretested. Human subject approvals were
received in both the United States and Russia at each
stage of this project. This approval was in compliance
with the Helsinki Declaration and the final study
approval was given by RTI International’sO f f i c eo f
Research Protection and Ethics, Protocol Number
11870.
Some of the formative activities to support the adapta-
tion provided a better understanding of the risk beha-
viors among these women and how to address these
behaviors within the life context of Russian women. The
results supported the notion of the intersection of dis-
empowered women using drugs and facing increased
HIV risk associated with their use of injecting equip-
ment and high-risk sex practices. The most salient find-
ing was that in order to maintain their own drug
addiction, many boyfriends and husbands were sending
the women out to trade sex for heroin.
Treatment Setting
Typically, LRCA patients receiving treatment for alcohol
and/or other drug abuse remain in the hospital for 3 to
4 weeks for treatment of withdrawal. Patients are stabi-
lized during the first 7 to 10 days, and once stabilized
they are detoxified. HIV testing also occurs during this
period. In addition, related psychiatric and somatic pro-
blems are addressed during the inpatient stay.
The most common drugs used to treat the signs and
symptoms of heroin withdrawal were clonidine, non-
opioid analgesics, hypnotics, and an antidiarrheal.
Patients do not receive any medication-assisted therapy,
as it is illegal in Russia to use opioid agonist medica-
tions to treat addiction or pain. Substance abuse treat-
ment also includes individual and group cognitive and
behavioral relapse prevention therapy.
Screening, Recruitment, and Randomization
Participants for the small randomized controlled trial
(RCT) were drawn from inpatients at LRCA who were
identified and approached by staff or from self-referrals
based on posted advertisements within the clinic. Parti-
cipation in the study was voluntary, and decisions to
participate or not to participate did not affect receipt of
treatment services. Eligibility criteria included being
female, self-reported injection drug use in the past year,
current LRCA substance abuse treatment for more than
4 days (total treatment varies from 7 days to 4 weeks),
being 18 to 30 years old, being able to sign informed
consent, not currently in any other research study, and
providing verifiable locator information in the St. Peters-
burg area to facilitate contact by field staff for follow-up
assessment. Women received an HIV antibody test at
admission and were being detoxified, so no further drug
testing was conducted. Women who met study eligibility
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informed consent document and provided written
informed consent. The informed consent document
included a description of the study and the randomiza-
tion process. A total of 100 women were randomized
into one of two 1-hour long intervention conditions–the
Woman-Focused intervention (n =5 1 )o raN u t r i t i o n
time-and-attention-matched control condition (n = 49).
Data Collection and Study Process
All consents, data collection, and interventions were
translated into Russian and back-translated by LRCA
staff. Interviews were conducted in a private office by a
trained female interviewer either immediately after or
up to a few days post-consent. The intake instrument
included questions on demographics, lifetime/current
alcohol and other drug use, drug injecting practices, sex
behaviors, conflict and victimization, mental health, and
physical health. Because it was voluntary, after comple-
tion of the baseline interview, all participants were asked
to return within the next few days for their first inter-
vention appointment. A follow-up questionnaire was
administered approximately 3 months post
randomization.
Participants in both intervention conditions were
asked to return in a week for the second intervention
session. Although they were still inpatients, these
requests were all voluntary and separate from patients’
daily routines. Both intervention sessions lasted about 1
hour and were conducted by an LRCA staff psycholo-
gist. Upon completion of either intervention condition,
women received 500 rubles (about USD$20) for their
time. At the follow-up visit, which occurred about 3
months after the first intervention session, participants
were asked to provide a urine sample for drug testing
and took part in a single assessment interview compris-
ing questions similar to the baseline questionnaire. This
visit lasted about 90 minutes. At the completion of the
follow-up appointment, the women received 1000 rubles
(about USD$40) for their time, a completion certificate,
and a risk-reduction kit.
Woman-Focused Intervention
The Woman-Focused intervention was developed ori-
ginally for substance-abusing African American women
in the United States [19] and subsequently adapted for
South African women [23,24]. This intervention is inter-
active, manual-driven, and focuses on empowering
women through educational activities, skill-building
demonstrations, guided practice, and role-playing. Infor-
mation is presented on cue-cards that provide structure
while allowing the interventionist the flexibility to tailor
the content to the needs of individual participants. The
sessions are delivered by a female staff psychologist who
has been trained on the intervention.
The intervention adapted for Russian women com-
prises two sessions that address the risks women face in
relation to their injection drug use and sex-risk behavior
for HIV. Issues of violence among Russia women,
including developing skills for violence prevention, are
also discussed. Session 1 covers general information on
HIV, risks associated with alcohol and other drug use,
injection drug use, benefits of substance abuse treat-
ment, hepatitis C virus, sexually transmitted infections,
strategies for reducing sex risk, and harm reduction.
Session 2 covers substance abuse and relationships, phy-
sical and sexual abuse, rape and violence prevention,
ways of discussing and negotiating safer sex, HIV test
results, and developing an action plan for reducing sub-
stance abuse and HIV risk.
Women randomized to the Woman-Focused condi-
t i o nr e c e i v e dt h ei n t e r v e n t i o nv i aao n e - o n - o n es e s s i o n
while they were LRCA inpatients. At the end of the sec-
ond session, women created a personalized risk-reduc-
tion plan to help them reduce their sex risk behaviors,
substance use, and physical and sexual victimization.
Other LRCA staff conducted data collection, quality
assurance, and data entry.
Nutrition Intervention
The equal-attention control group received a two-ses-
sion intervention adapted from the Colorado State Uni-
versity Extension Nutrition Program’s “Eat Well for
Less” (EWFL) curriculum. EWFL was developed with
funding from federal and local food stamp programs
and the US Department of Agriculture. It was chosen as
the equal-attention control group for its reliance on best
nutrition practices as well as its explicit discussion of
healthy eating with limited resources [25].
EWFL is interactive in ways similar to the Woman-
Focused intervention in that it encourages evaluating
the pros and cons associated with healthful choices and
guides the participant into goal-setting activities. It was
adapted to make it more culturally appropriate for Rus-
sian women, including how staples in the Russian diet,
such as the potato, can be cooked in several healthy
ways. This adaptation also incorporated cabbage and
other food groups, and demonstrated new ways to cook
to retain the nutrients in foods as well as additional sug-
gestions for a healthy lifestyle.
Training and Supervision of Staff
With the assistance of a translator, the Principal Investi-
gator helped to train the interventionists. The field
supervisor trained the data collectors. A multilingual
project director from LRCA served as a senior team
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observations.
Measures
Study interviews were conducted using a Russian-
adapted Revised Risk Behavior Assessment (RRBA) for
women [27]. Drug use measures (lifetime, past year, and
past 30 days before treatment entry), assessed 10 specific
substances: alcohol, marijuana, ecstasy, crack cocaine,
cocaine, heroin, amphetamine/methamphetamine,
tobacco, methadone, and “Jeff” or “ephedrone” (i.e., an
oxidation product of ephedrine). The primary drug-
related outcomes for this stu d yw e r ei n j e c t i o n - r e l a t e d
HIV-risk behaviors (i.e., receptive syringe sharing, indir-
ect sharing [sharing of cookers and cottons], and syr-
inge-mediated drug sharing [sharing liquefied drugs that
have been prepared with water added from a used
syringe]).
The RRBA contains questions about vaginal, oral and
anal contact, which generate counts of these specific sex
behaviors in the month prior to the interview, as well as
the number of episodes where condoms are used. These
items were computed to yield 30-day counts of unpro-
tected vaginal intercourse, oral sex and anal intercourse,
which represent the primary sex behavior outcomes of
this study. “Impaired sex” was defined as having sexual
relations under the influence of substances. This report
focuses on drug and sex risk as the two primary
outcomes.
Follow-up Rates
At 3 months, 91% of the sample had completed inter-
views. Women were tracked for follow-up in the sur-
rounding region.
Analysis
Descriptive statistics were compiled on baseline charac-
teristics of the participants. Using t-tests for continuous
variables and chi-square tests of association for categori-
cal variables, baseline differences were examined in key
study outcomes by intervention condition to assess the
equivalence of the study intervention conditions. Addi-
tionally, the results of t-tests and chi-square tests of
association were examined at 3-month follow-up to
determine if any post-intervention differences existed
between participants in the Nutrition and Woman-
Focused conditions.
Because the counts of risky behaviors were relatively
high, ordinary regression analysis was used rather than
Poisson. A general linear model was used for continuous
outcomes, which included the baseline status and the
intervention group indicator. Logistic regression using
the same model was used for binary outcomes. Catego-
rical variables were dichotomized. All of the analyses
were conducted using SAS version 9.2. These analyses
focused on drug use and sex risk and change at 3
months.
Results
Demographic information
Table 1 presents the participants’ demographics as well
as baseline information on key risk behaviors. Partici-
pants were, on average, 26 years old; the majority had at
least a high school education (80%); and they were
involved with a heterosexual main partner (68%). All of
the participants were IDUs, with a mean age of 18.5 at
the first time they injected drugs. Almost a quarter of
the participants had an intimate partner help them the
first time they injected drugs and 50% had shared works
in their lifetime. More than half of the participants
(57%) had been told that they were HIV-positive, as
they were tested upon inpatient treatment entry. Slightly
less than half of the sample had ever traded sex for
drugs, money, clothing, shelter, or any other goods
(44%).
Baseline risk behavior
Among the participants, 37% used protection the last
time they had sex with their main partner, and they
reported an average of eight unprotected vaginal sex
acts with their main partner in the 30 days prior to
entering treatment. Almost a third (30%) of the partici-
pants traded sex in the 30 days prior to entering treat-
ment and they reported an average of four unprotected
sex acts with sex-trading partners during that time.
Almost 90% of the participants were impaired (i.e., used
alcohol or other drugs) just before or during the last
time they had sex, in contrast with 36% of their part-
ners. In addition, 39% of the participants had unpro-
tected vaginal sex while they were impaired.
Injection risk behaviors were prevalent in this sample,
with all women injecting drugs; the most common drug
being heroin. On average, women were injecting heroin
almost daily prior to entering LRCA for drug abuse
treatment, and admission to treatment was prior to
enrollment in the study.
While all women in the study were heroin users, in
the 30 days prior to entering treatment, 46% of the
women also had injected cocaine and 44% also had
injected “speedball” (i.e., a mixture of heroin and
cocaine). In addition, participants engaged in risky drug
use behaviors such as indirect sharing practices (i.e.,
sharing cotton, cooker/spoon, or rinse water) or syringe-
mediated drug sharing (i.e., preparing drugs with water
from a used syringe and/or measuring and dividing
liquefied drugs with a used syringe–see Table 2). Other
drugs used in the 30 days prior to entering treatment
included marijuana (59%), ecstasy (53%), crack (46%),
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because all of the study participants were in treatment
for and were recently detoxified from heroin, the change
in heroin injection behavior is the most salient drug
outcome in the current study and therefore has the
greater analytic focus on days of use.
Analysis over time
Analyses over time (mean or percentage presented in
Table 2), paired t-tests (t) for continuous variables, and
the McNemar test for the significance of change (S) for
binary variables showed significant changes in several
outcome variables. Sex-risk behavior frequencies showed
some reduction over time. Primarily, there was a signifi-
cant increase in the percentage of participants who used
protection during the last sex contact with their main
partner (Baseline = 36.7%; Follow-up = 59.5%; S = 7.12
[1], p = 0.01). Additionally, unprotected vaginal sex acts
with main sex partner significantly reduced over time (t
= 2.57 [50], p = 0.01) and this finding was driven by sig-
nificant reductions in the Woman-Focused condition (t
= 3.31 [27], p = 0.003) as compared with the Nutrition
condition. Participants’ impairment at last sex contact
with any partner also showed significant improvement,
with 89.7% of participants reporting some alcohol and/
or other drug use at baseline before or during sex,
whereas 78.2% of participants reported sexual contact
while impaired at follow-up (S = 4.67 [1], p < .05).
The frequency of risky drug use injection behaviors,
such as the average number of injections in the past 30
days, showed a significant reduction (Baseline M =9 6 . 7 ;
Follow-up M = 42.0; t = 10.35 [72], p < 0.0001). In addi-
tion, the average number of days that participants
injected heroin by itself also showed a significant reduc-
tion (Baseline M = 28.5; Follow-up M = 14.7; t = 9.48
[89], p < 0.0001). Other past 30-day injection risk beha-
viors, such as the average number of times a participant
injected drugs mixed with water from another injector’s
syringe, also showed a significant reduction (Baseline M
= 7.2; Follow-up M = 0.5; t = 2.31 [28], p = 0.03).
Finally, the number of times a participant shared their
own cotton, cooker, or water showed a significant
reduction (Baseline M = 6.0; Follow-up M =1 . 5 ;t=
2.45 [71], p = 0.02) as well as the number of times a
participant used a cotton, cooker, or water from some-
one else (Baseline M = 8.0; Follow-up M =1 . 2 ;t=2 . 3 2
[27], p = 0.03).
Intervention effect
To estimate the effect of the intervention on salient out-
comes, the analysis dataset was limited to only those
participants who completed the baseline and follow-up
interviews. An assessment of attrition cases yielded no
significant differences on baseline characteristics
between participants who completed the study and
those who dropped out. Subsequently, a series of regres-
sion models was conducted for each of the outcomes
(sex- and injection-risk behaviors) and the value of the
intervention coefficient and the effect of the baseline
value were estimated. The results of these analyses
Table 1 Study Sample (N = 100) Demographic Characteristics
Total
Sample
(N = 100)
Nutrition
Condition
(n = 49)
Woman-Focused Intervention
Condition
(n = 51)
n (%)
a or M (SD)
Mean age 25.9 (SD =
3.0)
26.0 (SD = 2.8) 25.7 (SD = 3.1)
Education
Less than high school 20 (20%) 12 (24.5%) 8 (15.7%)
High school or greater 80 (80%) 37 (75.5%) 43 (84.3%)
Marital status
Single 17 (17%) 8 (16.3%) 9 (17.7%)
Involved, Married, or Living as Married 68 (68%) 32 (65.3%) 36 (70.6%)
Separated, Divorced, Widowed 15 (15%) 9 (18.4%) 6 (11.8%)
Ever told HIV+ (yes) 57 (57%) 26 (53.1%) 31 (60.8%)
Ever traded sex for drugs, money, clothing, shelter, or any other goods
(yes)
44 (44.4%) 22 (44.9%) 22 (44.0%)
Ever used a female condom with main sex partner (yes)
b 2 (2.8%) 1 (2.9%) 1 (2.7%)
Mean age at first time injected 18.5 (3.2 SD) 18.9 (3.3 SD) 18.1 (3.0 SD)
Intimate partner helped inject first time (yes) 22 (22%) 10 (20.8%) 12 (23.5%)
Ever shared works that had been used by someone else (yes) 50 (50%) 21 (42.9%) 29 (56.9%)
a Percentage of participants who responded Yes within the given intervention group
b Of those that had main sex partners
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vals [CIs]) are presented in Table 3.
As indicated previously, intervention status had a sig-
nificant effect on the average number of unprotected
vaginal sex acts with a main partner, with participants
in the Woman-Focused condition reporting significantly
fewer unprotected sex acts than participants in the
Nutrition condition. Intervention status also had a sig-
nificant effect on participants reporting partner
impairment at last sex contact with their main partner,
with fewer participants in the Woman-Focused condi-
tion reporting partner impairment than participants in
the Nutrition condition.
Discussion
Several notable findings emerged from this first exami-
nation of the feasibility and efficacy of this evidence-
based intervention modified for female IDUs in St.
Table 2 Baseline and 3-Month Follow-up Sex- and Drug-Risk Behaviors
Baseline (N = 100) 3-Month Follow-up (N = 91)
Outcome Measure
n (%)
a or M (SD)
Baseline
Total
Sample
(N = 100)
Nutrition
Condition
(n = 49)
Woman-Focused
Intervention
Condition
(n = 51)
b
Follow-up
Total
Sample
(N = 91)
Nutrition
Condition
(n = 42)
Woman-Focused
Intervention
Condition
(n = 49)
Traded sex for drugs, money, clothing, shelter, or any other
goods in 90 days prior to drug treatment (yes)
30 (30%) 16 (32.7%) 14 (27.5%) 38 (41.8%) 14 (33.3%) 24 (49.0%)
Protected last sex acts with main sex partner (yes)
c 18 (36.7%) 9 (37.5%) 9 (36%) 47 (59.5%)
++
16 (47.1%) 31 (68.9%)*
Mean number unprotected vaginal sex acts with main sex
partner in 30 days prior to entering drug treatment
c
7.8 (8.8
SD)
6.4 (7.8
SD)
9.0 (9.5 SD) 4.3 (5.8
SD)++
6.4 (6.8
SD)
2.6 (4.2 SD)**
Mean number unprotected sex acts with sex trading
partner in 30 days prior to entering drug treatment
4.1 (19.6
SD)
7.5 (26.6
SD)
0.2 (0.6 SD) 2.3 (13.1
SD)
5.5 (20.6
SD)
0.1 (0.4 SD)
Impaired last sex (yes)
Participant 87 (89.7%) 40 (85.1%) 47 (94.0%) 68 (78.2%)
+
30 (75.0%) 38 (80.9%)
Partner 35 (36.1%) 15 (31.9%) 20 (40.0%) 20 (23.0%) 12 (30.0%) 8 (17.0%)
Impaired last vaginal sex - Unprotected (yes) 38 (39.2%) 18 (38.3%) 20 (40.0%) 26 (29.9%) 12 (30.0%) 14 (29.8%)
Last sex with main sex partner using female condom (yes)
c 0 0 0 8 (12.1%) 0 8 (18.6%)*
Mean number of injections in past 30 days prior to drug
treatment
96.7 (40.0
SD)
99.1 (41.6
SD)
94.6 (39.0 SD) 42.0 (40.2
SD)
44.6 (40.1
SD)
39.6 (40.6 SD)
Mean number of times used cotton, cooker/spoon, or rinse
water used by someone else in past 30 days
8.0 (19.8
SD)
3.4 (6.8
SD)
12.0 (24.0 SD) 0.6 (2.7
SD)
1.2 (3.9
SD)
0.1 (0.4 SD)
Mean number of times someone else used your cotton,
cooker/spoon, or rinse water in past 30 days
6.0 (17.8
SD)
3.1 (8.8
SD)
8.5 (22.7 SD) 1.2 (2.8
SD)
1.5 (3.1
SD)
1.0 (2.7 SD)
Mean number of times injected drugs mixed with water
from someone else’s syringe in the past 30 days (i.e.
syringe-mediated drug sharing)
7.2 (18.3
SD)
1.7 (4.5
SD)
12.8 (24.5 SD)* 0.5 (1.6
SD)
0.9 (2.2
SD)
0.1 (0.5 SD)*
Mean days injected
heroin only
28.5 (5.8
SD)
28.1 (6.9
SD)
28.9 (4.8 SD) 14.7 (13.0
SD)
15.4 (13.8
SD)
14.0 (12.3 SD)
Any drugs injected
Cocaine only 41 (45.6%) 19 (44.2%) 22 (46.8%) 1 (1.1%) 1 (2.4%) 0
Heroin and cocaine 41 (44.1%) 19 (41.3%) 22 (46.8%) 3 (3.3%) 2 (4.8%) 1 (2.0%)
Any drugs smoked/snorted,
Marijuana 43 (58.9%) 19 (55.9%) 24 (61.5%) 10 (11.0%) 4 (9.5%) 6 (12.2%)
Ecstasy only 43 (53.1%) 19 (51.4%) 24 (54.6%) 8 (8.8%) 3 (7.1%) 5 (10.2%)
Crack/cocaine only 41 (46.1%) 19 (44.2%) 22 (47.8%) 4 (4.4%) 1 (2.4%) 3 (6.1%)
Heroin only 42 (51.9%) 19 (48.7%) 23 (54.8%) 0 0 0
Jeff 19 (24.1%) 8 (21.1%) 11 (26.8%) 2 (2.2%) 1 (2.4%) 1 (2.0%)
a Percentage of participants who responded Yes within the given intervention group, some variable have missing responses due to lack of relevance for
individual participants.
b “*” Markings of significance indicate significant group differences between the Nutrition and the Woman-focused intervention groups within time (i.e., baseline
or3-month follow-up). “+"Markings of significance indicate significant over time differences either overall, or within the Nutrition or the Woman-focused
intervention group.
c Of those that had main sex partners and had intercourse with them.
*p < .05; **p < .01; ***p < .001
+p < .05; ++p < .01; +++p < .001
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and sex risk makes this study vital to addressing these
issues. First, the fact that almost 6 of every 10 partici-
pants (57%) were HIV-positive is highly disproportional
and emphasizes the need to implement effective HIV
prevention and intervention for this high-risk population
of women. Living within a male-dominated society that
often leaves them without other economic opportunities
and unable to negotiate safer sex behaviors, these
women and the men they have sex with represent
important drivers of the HIV epidemic in Russia. Sec-
ond, the fact that, on average, participants in each inter-
vention condition reduced drug injection in the number
of days used and number of times used in a month
affirms the importance of substance abuse treatment to
improve drug risk outcomes. Third, the results suggest
that, on average, the Woman-Focused condition pro-
duced greater reductions in sex-risk behaviors (e.g., less
unprotected vaginal sex acts) with main sex partners, as
compared with the Nutrition condition. These results
are similar to the results seen with the Women’sC o O p
in other cultural settings [28].
Taken together, the results from this initial feasibility
study of the adaption of the Women’sC o O pf o rf e m a l e
IDUs in Russia suggest that this intervention was suc-
cessful in teaching women the needed skills to negotiate
condom use and protected sex with main partners.
However, although the intervention did not stop drug
use at 3 months or trading behaviors that are also asso-
ciated with how drugs are obtained, harm-reduction
methods were utilized in teaching about drug use and
injecting risk, and how to reduce risk. The findings are
not definitive, but they underscore the importance of
future research to more fully examine the efficacy of the
Women’s CoOp with female IDUs in Russia.
Although significant reductions in both drug use and
sex-risk behaviors occurred in both intervention condi-
tions, no difference is evident between the conditions
with regard to reductions in heroin use. This may have
been confounded by the fact that all of the study
Table 3 Regression Analyses With 3-Month Follow-up Behaviors as Outcomes and Controlling for Each Outcome
Variable’s Baseline Status*
Regression coefficient
corresponding to the Baseline
Status
Parameter Estimate (SE)
a
/Odds Ratio (95% CI)
b
Regression coefficient
corresponding to the Intervention
Group
Parameter Estimate (SE)
/Odds Ratio (95% CI)
Parameter Estimate (SE) or Odds Ratio (95% CI)
Traded sex for drugs, money, clothing, shelter, or any other goods in past
90 days (yes)
1.02 (0.27-3.84)
Wald Χ
2 = 0.001 (1), p = 0.98
0.92 (0.25-3.34)
Wald Χ
2 = 0.02 (1), p = 0.90
Any protected last sex act with main sex partner (yes) 0.23 (0.05-1.00)
Wald Χ
2 = 3.87 (1), p = 0.05
1.66 (0.46-6.03)
Wald Χ
2 = 0.60 (1), p = 0.44
Mean number of unprotected vaginal sex acts with main sex partner in
past 30 days
0.24 (0.09)
t = 2.69 (1), p = 0.01
-4.56 (1.64)
t = -2.77 (1), p = 0.008
Mean number of unprotected sex acts with sex- trading partner in past
30 days
-0.07 (0.25)
t = -0.27 (1), p = 0.79
-9.18 (14.58)
t = -0.63 (1), p = 0.54
Impaired last sex (yes)
Participant 0.18 (0.04-0.78)
Wald Χ
2 = 5.26 (1), p = 0.02
1.43 (0.47-4.29)
Wald Χ
2 = 0.40 (1), p = 0.53
Partner 0.17 (0.05-0.54)
Wald Χ
2 = 9.13 (1), p = 0.003
0.31 (0.10-0.98)
Wald Χ
2 = 3.97 (1), p = 0.05
Impaired last unprotected vaginal intercourse (yes) 0.02 (0.004-0.07)
Wald Χ
2 = 30.75 (1), p < 0.0001
0.91 (0.22-3.83)
Wald Χ
2 = 0.02 (1), p = 0.90
Mean number of injections in past 30 days 0.25 (0.12)
t = 2.07 (1), p = 0.04
-3.90 (9.26)
t = -0.42 (1), p = 0.67
Mean number of times used cotton, cooker/spoon, or rinse water used
by someone else in past 30 days
0.01 (0.02)
t = 0.57 (1), p = 0.57
-1.16 (0.83)
t = -1.39 (1), p = 0.18
Mean number of times someone else used your cotton, cooker/spoon, or
rinse water in past 30 days
0.01 (0.02)
t = 0.36 (1), p = 0.72
-0.56 (0.69)
t = -0.81 (1), p = 0.42
Mean number of times injected drugs mixed with water from someone
else’s syringe in past 30 days (i.e. syringe-mediated drug sharing)
0.01 (0.01)
t = 0.48 (1), p = 0.63
-0.76 (0.47)
t = -1.61 (1), p = 0.12
Mean number of days injected heroin in past 30 days 0.21 (0.24)
t = 0.88 (1), p = 0.38
-1.27 (2.76)
t = -0.46 (1), p = 0.65
*The regression has the form: Outcome = Intercept + b1* Baseline Status+ b2* Intervention Group + error or Logit[P(Outcome = 1)] = Intercept + b1* Baseline Status+
b2* Intervention Group
a Table input for linear regression
b Table input for logistic regression
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fied from heroin, and some contamination between the
conditions may have occurred. Russian law allows treat-
ment of opioid dependence with antagonist medications
such as naltrexone, which is superior to placebo [29];
however, the study participants were in detoxification
and did not receive it. Furthermore, Russian law does
not allow for treatment with opioid agonist medications,
such as methadone or buprenorphine, which are super-
ior to placebo conditions and yield improvement in
long-term outcomes [30,31].A c c e s st ot h ef u l lc o n t i -
nuum of medication options for opioid dependence
would likely improve the transient benefits of any short-
term brief intervention with detoxification. These fleet-
ing benefits are evidenced by the fact that, as seen in
the average number of days heroin was injected, at their
3-month follow-up interview most participants were
injecting heroin every other day.
The strengths of this initial feasibility and efficacy
study include its design features, such as randomization
to conditions and that the control condition was
matched for time and attention. Additionally, the 91%
completion rate at the 3-month follow-up interview
leaves little opportunity for missing data to compromise
the results.
However, the study has several limitations. First, the
extent to which small intervention studies, such as this
one, successfully conducted within a hospital setting can
be generalized to larger community settings is unknown.
Second, in contrast to some other examinations of the
Women’s CoOp, this study tested the feasibility of the
intervention in the context of inpatient substance abuse
treatment. This setting and the services received in this
context may have compromised the ability to see
improvements specific to the Women’sC o O pw h e r e
contamination may have occurred. Third, the small
sample size may have provided insufficient power to
detect significant changes in some of the outcomes or
any long-term sustainability, especially with regard to
sex-risk reduction. However, with the piloted sample,
the study had 76% power to detect an observed effect
size of 0.5 at a probability level of 0.05. Fourth, despite
the RRBA being translated and revised for this study,
further research establishing its reliability and validity
with Russian female IDUs is needed. Nevertheless, the
results from this study suggest that future research
should examine the Women’s CoOp as a potentially effi-
cacious intervention for a population in dire need of
such an HIV prevention intervention. In addition, this
study used a nutrition intervention for comparison,
which does not provide information on the relative effi-
cacy of the intervention compared with other HIV pre-
vention interventions. Finally, given the large number of
tests and a liberal alpha level of 0.05, there is a likeli-
hood of Type I error in these findings.
Overall, this small trial was successful for the Woman-
Focused condition (e.g., addressing drug risk and sex
risk). Larger trials with female IDUs across settings are
needed to replicate and extend the promising results
found here. In addition, policy changes are needed within
the Russian substance abuse treatment system to legalize
a continuum of proven treatment options for female
IDUs who also are at risk for HIV, other health related
issues, and gender-based violence. Finally, because most
of the women in this at-risk population are of childbear-
ing age, successful interventions for them have the poten-
tial to also benefit future generations.
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